1. Financial evolution
1.1. Costs
1.2. Revenue
2. Executive Summary
3. Describe Objectives
4. Marketing Strategy
4.1. Timing and Customer / Market Expectation : Regolatory Impact
4.1.1. Expectations on 2025 Budget
4.1.2. Risks and Benefits on Multi Year Plan 2025 / 2028
5. Financial Plan and Projections 2024 / 2028 based on Product's pipeline
5.1. Capacity
5.2. Risks and Benefits
5.3. Debottlenecking
5.4. Plan and Evolution Capacity / Risks / Costs / Revenue on Manufacturing based on Marketing Evolution
6. Strategy and Implementation of Leuprolide Product
7. Strategy and Implementation of Enoxaparin Product
8. Strategy and Implementation of Benserazide Product
9. Utilities Empowerment Program
9.1. Power Energy
9.1.1. Budget Costs
9.1.2. Evolution Costs
9.2. Cooling Tower
9.3. Steam Empowerment Phase 1
9.4. Purified Water
9.5. Well A maintenance
10. Strategy and Implementation of 5ASA Project
10.1. Carboxilators
10.1.1. Status
10.1.2. Investments and dependencies
10.2. Potassium Carbonate Reduction
10.2.1. Status
10.2.2. Investments and dependencies
10.2.3. Compliance Impacts
10.2.4. Risks / Benefits analysis based on Capacity installed and Market evolution
10.3. Octopus
10.3.1. Status
10.3.2. Investments and dependencies
10.3.3. Compliance Impacts
11. Strategy and Implementation of Givinostat Project
11.1. Status
11.2. Investments and dependencies
11.2.1. Low Costs Solution RS3
11.2.1.1. Timing
11.2.1.2. IRR
11.2.1.3. ROI / Deprecation
11.2.2. Basic Solution Area 10
11.2.2.1. Timing
11.2.2.2. IRR
11.2.2.3. ROI / Deprecation
11.2.3. High Costs Solution MPP
11.2.3.1. Timing
11.2.3.2. IRR
11.2.3.3. ROI / Deprecation
11.3. Compliance Impacts
11.3.1. AIA / AIFA impact
12. Strategy And Implementation of GPC Project
12.1. Status
12.2. Investments and dependencies
12.2.1. GPC 2.0
12.2.1.1. Timing
12.2.1.2. IRR
12.2.1.3. ROI / Deprecation
12.2.2. GPC 3.0
12.2.2.1. Timing
12.2.2.2. IRR
12.2.2.3. ROI / Deprecation
12.3. Compliance Impacts
12.3.1. Financial evolution
12.3.1.1. Costs
12.3.1.2. Revenue
12.3.2. AIA / AIFA impact
13. Strategy And Implementation of Ferrolat Project
13.1. Status
13.2. Investments and dependencies
13.2.1. Actual Technology solution
13.2.1.1. Timing
13.2.1.2. IRR
13.2.1.3. ROI / Deprecation
13.2.2. New Technology Solution
13.2.2.1. Timing
13.2.2.2. IRR
13.2.2.3. ROI / Deprecation
13.3. OPP Revolution Project
13.4. Compliance Impacts
13.4.1. Financial evolution
13.4.1.1. Costs
13.4.1.2. Revenue
13.4.2. AIA / AIFA impact
14. WHS Improvement for Degest
14.1. Solution Buy
14.1.1. Revamping
14.1.1.1. Regolatory Time and AIFA/AIA
14.2. Rent to Buy
14.2.1. Revamping
14.2.1.1. Regolatory Time and AIFA / AIA
15. Strategy And Implementation of Octeotride Project
15.1. Status
15.2. Investments and dependencies
15.2.1. Execution
15.2.1.1. Timing
15.2.1.2. IRR
15.2.1.3. ROI / Deprecation
15.3. Compliance Impacts
15.3.1. Financial evolution
15.3.1.1. Costs
15.3.1.2. Revenue
15.3.2. AIFA impact
16. Strategy and Implementation of Bupropion HCl - HBr Project
16.1. Status
16.2. Investments and dependencies
16.2.1. Execution
16.2.1.1. Timing
16.2.1.2. IRR
16.2.1.3. ROI / Deprecation
16.3. Compliance Impacts
16.3.1. Financial evolution
16.3.1.1. Costs
16.3.1.2. Revenue
16.3.2. AIFA impact